HTML
Droplet Digital PCR (ddPCR) technology is being used to identify cancer subtypes, optimize drug treatment plans, monitor residual disease, and study tumor evolution. The recently released Automated Droplet Generator enables minimal hands-on time, high throughput, and consistent droplets from any user. Bio-Rad also has assays that target top mutations and other cancer targets readily available for use; no optimization required. Dr. Dawne Shelton discusses how these ddPCR tools will enable your research endeavors.